
1. mol cell biol. 2000 sep;20(17):6483-95.

human papillomavirus type 16 e7 oncoprotein binds inactivates
growth-inhibitory insulin-like growth factor binding protein 3.

mannhardt b(1), weinzimer sa, wagner m, fiedler m, cohen p, jansen-d√ºrr p,
zwerschke w.

author information: 
(1)deutsches krebsforschungszentrum, forschungsschwerpunkt angewandte
tumorvirologie, inf 242, d-69120 heidelberg, germany.

the e7 protein encoded human papillomavirus type 16 one viral
genes immortalize primary human cells thereby override cellular
senescence. generally assumed property e7 depends its
interaction regulators cell cycle, show e7 targets
insulin-like growth factor binding protein 3 (igfbp-3), product a
p53-inducible gene overexpressed senescent cells. igfbp-3 suppress
cell proliferation induce apoptosis; show igfbp-3-mediated
apoptosis inhibited e7, binds igfbp-3 triggers proteolytic
cleavage. two transformation-deficient mutants e7 failed inactivate
igfbp-3, suggesting inactivation igfbp-3 may contribute cell
transformation.

doi: 10.1128/mcb.20.17.6483-6495.2000 
pmcid: pmc86123
pmid: 10938125  [indexed medline]

